Lundgren J D, Barton S E, Lazzarin A, Danner S, Goebel F D, Pehrson P, Mulcahy F, Kosmidis J, Pedersen C, Phillips A N
Hvidovre Hospital, Denmark.
Clin Infect Dis. 1995 Jul;21(1):106-13. doi: 10.1093/clinids/21.1.106.
This study examined the factors associated with the development of a first episode of Pneumocystis carinii pneumonia (PCP) in 5,025 patients with AIDS, including 1,976 patients with primary PCP at the time of AIDS diagnosis and 635 with primary PCP occurring subsequently. Compared with untreated patients, patients treated with zidovudine were at similar risk of developing PCP during the first year of therapy but were at greater risk after longer intervals of treatment. The following factors were associated with an increased risk of PCP (either at the time of AIDS diagnosis or thereafter): lack of primary PCP prophylaxis, male homosexuality/bisexuality, diagnosis of AIDS in northern Europe, and CD4 cell count below 200 x 10(6)/L at the time of AIDS diagnosis. Patients with severe weight loss had a 60% higher risk of developing PCP during follow-up than those without such weight loss. Thus, the occurrence of PCP depended on geographic location, mode of acquisition of human immunodeficiency virus and AIDS, degree of immunodeficiency, and use of various treatment regimens.
本研究调查了5025例艾滋病患者首次发生卡氏肺孢子虫肺炎(PCP)的相关因素,其中包括1976例在艾滋病诊断时即患有原发性PCP的患者以及635例随后发生原发性PCP的患者。与未接受治疗的患者相比,接受齐多夫定治疗的患者在治疗的第一年发生PCP的风险相似,但在治疗时间更长后风险更高。以下因素与PCP风险增加相关(无论是在艾滋病诊断时还是之后):未进行原发性PCP预防、男性同性恋/双性恋、在北欧诊断为艾滋病以及在艾滋病诊断时CD4细胞计数低于200×10⁶/L。严重体重减轻的患者在随访期间发生PCP的风险比未体重减轻的患者高60%。因此,PCP的发生取决于地理位置、人类免疫缺陷病毒和艾滋病的感染方式、免疫缺陷程度以及各种治疗方案的使用情况。